Sort
85,873 grants matching “alzheimers”
Midlife cardiovascular stress physiology and preclinical cerebrovascular disease
$744,861Peter J Gianaros · University Of Pittsburgh At Pittsburgh · R01 · FY2025 · HL
DYRK1A Inhibition as a Novel Treatment Approach for Alzheimer's Disease
$744,799Christopher Hulme · University Of Arizona · R01 · FY2023 · AG
Clinical
$744,798Randall J Bateman · Washington University · U01 · FY2009 · AG
ORCASTRAIT Oregon Roybal Center for Care Support Translational Research Advantaged by Integrating Technology
$744,793Jeffrey A Kaye · Oregon Health & Science University · P30 · FY2022 · AG
Deciphering the regulation of gene expression in the etiology of LOAD
$744,721Ornit Chiba-Falek · Duke University · R01 · FY2018 · AG
Neural Mechanisms of Affective Salience in Aging
$744,719Lisa Feldman Barrett · Massachusetts General Hospital · R01 · FY2015 · AG
Pathophysiology of postoperative delirium and the use of biomimetic sleep as a treatment strategy in the CSICU
$744,708Oluwaseun Johnson-Akeju · Massachusetts General Hospital · R01 · FY2017 · AG
Pathophysiology of postoperative delirium and the use of biomimetic sleep as a treatment strategy in the CSICU
$744,708Oluwaseun Johnson-Akeju · Massachusetts General Hospital · R01 · FY2018 · AG
Nighttime Agitation and Restless Legs Syndrome in People with Alzheimer's Disease
$744,661Kathy C Richards · University Of Texas At Austin · R01 · FY2019 · AG
Genetic Approaches to Aging
$744,657Peter S Rabinovitch · University Of Washington · T32 · FY2006 · AG
Cross-study analysis of coordinated randomized clinical trials for weight managem
$744,634Steven H. Belle · University Of Pittsburgh At Pittsburgh · R01 · FY2016 · HL
Investigating Neuroenergetic Changes through Diet in Aging and Alzheimerâs Disease (INC-AD)
$744,628Matthew Taylor · University Of Kansas Medical Center · R61 · FY2024 · AG
Efficacy and Mechanisms of Combined Aerobic Exercise and Cognitive Training in MCI (The ACT Trial)
$744,622Fang Yu · University Of Minnesota · R01 · FY2019 · AG
MassaChusetts General Hospital ROybal CeNter For BehavIoral Dyadic ResEarch in Alzheimer's Disease and Related Dementias (CONFIDE-ADRD): Behavioral Intervention Development Core
$744,621Ana-Maria Vranceanu · Massachusetts General Hospital · P30 · FY2025 · AG
A Novel Small molecule TNF-alpha inhibitor as a disease-modifying AD drug treatment.
$744,572Somasundar Prasad Gabbita · P2d, Inc. · R44 · FY2016 · AG
Role of estradiol and related hormones on inflammation, sleep, and risks for Alzheimer's disease
$744,503Whitney Lee Wharton · Emory University · R01 · FY2020 · AG
Metabolic interactions in the vascular wall: an integrated experimental and computational approach
$744,490Alisa S Morss Clyne · Univ Of Maryland, College Park · R01 · FY2025 · HL
Role of Systemic Inflammation in Cognitive Decline: Rheumatoid Arthritis as a Prototype
$744,449Elena Myasoedova · Mayo Clinic Rochester · R01 · FY2021 · AG
Role of Systemic Inflammation in Cognitive Decline: Rheumatoid Arthritis as a Prototype
$744,449Elena Myasoedova · Mayo Clinic Rochester · R01 · FY2024 · AG
Role of Systemic Inflammation in Cognitive Decline: Rheumatoid Arthritis as a Prototype
$744,449Elena Myasoedova · Mayo Clinic Rochester · R01 · FY2023 · AG
Role of Systemic Inflammation in Cognitive Decline: Rheumatoid Arthritis as a Prototype
$744,449Elena Myasoedova · Mayo Clinic Rochester · R01 · FY2022 · AG
Molecular mechanisms of selective vulnerability of neurons to tauopathy
$744,445Martin Kampmann · University Of California, San Francisco · R01 · FY2023 · AG
Molecular mechanisms of selective vulnerability of neurons to tauopathy
$744,445Martin Kampmann · University Of California, San Francisco · R01 · FY2024 · AG
Compensation Training and Lifestyle Modifications to promote healthy aging in persons at risk for Alzheimer's disease: a digital application supported intervention
$744,436Sarah E Tomaszewski-Farias · University Of California At Davis · R01 · FY2022 · AG
Long-term Neuropsychiatric Sequelae of SARS-CoV-2 Infection in Late Life
$744,308Amy Lynn Byers · Northern California Institute/Res/Edu · R01 · FY2024 · AG